Zobrazeno 1 - 10
of 22
pro vyhledávání: '"N A Pogudina"'
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 2, Pp 22-29 (2021)
Objective: to review the data on the efficacy and consumption of octocog alfa and rurioctoctog alfa pegol in standard prophylaxis and individualized prophylaxis in hemophilia A patients based on published international data. Material and methods: a s
Externí odkaz:
https://doaj.org/article/d36975204b65479fb7c110928a23e0a0
Publikováno v:
Качественная клиническая практика, Vol 0, Iss 1, Pp 19-26 (2019)
Objective. To determine the clinical and economic consequences of the drug mepolizumab in patients with severe bronchial asthma (SBA) and the ineff ectiveness of omalizumab. Methods. We conducted cost-eff ectiveness and budget impact analysis of the
Externí odkaz:
https://doaj.org/article/a660953267b540c4a09652f7a00ad120
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 48-60 (2019)
The aim is to develop a generalized algorithm and methodology for conducting clinical and economic studies (CeS) on medications used in treatment of malignant neoplasms (MnP). Materials and methods. We conducted a literature search and then reviewed
Externí odkaz:
https://doaj.org/article/619eccab17ce4418969d4b9a9647ebb2
Autor:
A. G. Tolkushin, N. L. Pogudina
Publikováno v:
Фармакоэкономика, Vol 11, Iss 3, Pp 23-37 (2018)
The aim is to study the clinical and economic aspects of using belimumab for the treatment of systemic lupus erythematosus (SLe) in patients with high SLe activity, the presence of anti-DNA, a low level of complement in the blood plasma and minimal l
Externí odkaz:
https://doaj.org/article/36bf2d7778244a30a3793ab979bdc3d8
Autor:
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 22-30 (2017)
The recently introduced novel drug combinations for the treatment of COPD are based on long-acting beta-agonists (vilantererol / umeclidinum bromide) and long-acting anticholinergics (olodaterol / tiotropium bromide). In addition to their beneficial
Externí odkaz:
https://doaj.org/article/1d4f89ad2f9c43b4acf1d67df41135bb
Autor:
N. L. Pogudina, E. G. Kosolapov, F. S. Kochenkov, A. V. Karaulov, N. L. Bondarenko, D. V. Blinov
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 12-21 (2017)
Comparative pharmacoeconomic analysis of fixed-dose combinations (FDC) vilanterol / fluticasone furoate vs budesonide / formoterol was needed to identify the preferable FDC for asthma management.Study objective: to identify the preferable FDC of inha
Externí odkaz:
https://doaj.org/article/510e92d40fef4d478021f3c82e9a7a72
Publikováno v:
Фармакоэкономика, Vol 10, Iss 2, Pp 31-40 (2017)
In accordance with currently accepted recommendations for the diagnosis and treatment of chronic obstructive pulmonary disease (COPD), both monotherapy with long-acting anticholinergics (LAAC) or combined therapy (LAAC / long-acting beta-agonists, LA
Externí odkaz:
https://doaj.org/article/45a3d1dabd4645ce9114c79e5fe8b0e7
Publikováno v:
Фармакоэкономика, Vol 11, Iss 4, Pp 48-60 (2019)
The aimis to develop a generalized algorithm and methodology for conducting clinical and economic studies (CeS) on medications used in treatment of malignant neoplasms (MnP).Materials and methods. We conducted a literature search and then reviewed th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::467dd87fb3008570544076d2cdc7907c
https://www.pharmacoeconomics.ru/jour/article/view/270
https://www.pharmacoeconomics.ru/jour/article/view/270
Autor:
A. G. Tolkushin, N. L. Pogudina
Publikováno v:
Onkourologiâ, Vol 14, Iss 1, Pp 126-135 (2018)
Objective: to determine clinical and economic consequences of using the degarelix drug instead of gonadotropin-releasing hormone (GnRH) analogs for treatment of advanced hormone-sensitive prostate c ancer. Materials and methods. The main criteria of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92cd35a850d8f78a48086546ec4376d5
https://oncourology.abvpress.ru/oncur/article/view/811
https://oncourology.abvpress.ru/oncur/article/view/811